Product Code: ETC13408421 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Infectious Disease Point-of-care Testing Market was valued at USD 12.8 Billion in 2024 and is expected to reach USD 20.3 Billion by 2031, growing at a compound annual growth rate of 6.80% during the forecast period (2025-2031).
The Global Infectious Disease Point-of-care Testing Market is experiencing significant growth driven by the increasing prevalence of infectious diseases worldwide, the need for rapid and accurate diagnostic solutions, and the growing demand for decentralized testing options. Key factors such as the convenience of point-of-care testing, reduced turnaround time for results, and the rise in funding for healthcare infrastructure in developing regions are contributing to market expansion. Technological advancements in molecular diagnostics and the development of user-friendly devices are further propelling market growth. Key players in the market are focusing on product innovations, strategic collaborations, and geographical expansion to strengthen their market presence. The market is expected to continue to grow, driven by the ongoing efforts to combat infectious diseases and improve healthcare accessibility globally.
The Global Infectious Disease Point-of-care Testing Market is experiencing significant growth driven by the increasing prevalence of infectious diseases worldwide and the need for rapid and accurate diagnostic solutions. Key trends in the market include the rising demand for decentralized testing to enable quick decision-making, the development of innovative technologies such as molecular diagnostics for improved accuracy, and the expansion of testing capabilities to include a wider range of infectious diseases. Opportunities for market growth lie in the increasing adoption of point-of-care testing in resource-limited settings, the emphasis on early detection and treatment to curb disease spread, and the potential for market expansion in emerging economies. Overall, the market is poised for continued expansion as healthcare systems prioritize efficient and timely infectious disease diagnosis.
The Global Infectious Disease Point-of-care Testing Market faces several challenges, including the need for accurate and reliable testing methods, limited access to testing in remote or underdeveloped regions, regulatory hurdles for product approval, and the high cost associated with implementing point-of-care testing solutions. Additionally, ensuring proper training for healthcare professionals to use these tests effectively, maintaining quality control standards, and addressing issues related to data management and connectivity are also significant challenges in this market. As infectious diseases continue to pose a threat to public health worldwide, overcoming these challenges is crucial for the successful adoption and widespread use of point-of-care testing to enable timely and accurate diagnosis, ultimately leading to improved patient outcomes.
The Global Infectious Disease Point-of-care Testing Market is primarily driven by the increasing prevalence of infectious diseases worldwide, leading to a growing demand for rapid and accurate diagnostic solutions. Factors such as the rise in outbreaks of diseases like COVID-19, Zika, and Ebola have highlighted the need for quick and efficient testing at the point of care. Additionally, the advantages of point-of-care testing, such as faster turnaround times, reduced need for specialized laboratory equipment, and the ability to provide immediate results to patients, are also fueling market growth. Moreover, technological advancements in diagnostic devices, expanding healthcare infrastructure in developing regions, and the emphasis on early disease detection and management are further contributing to the market expansion.
Government policies related to the Global Infectious Disease Point-of-care Testing Market vary by region but generally focus on ensuring the safety, accuracy, and accessibility of point-of-care testing devices. Regulatory bodies, such as the FDA in the United States and the European Medicines Agency in the EU, oversee the approval and monitoring of these devices to ensure they meet quality standards and performance criteria. Additionally, governments may implement policies to promote the adoption of point-of-care testing in healthcare settings to improve disease detection and management, especially in remote or underserved areas. Reimbursement policies and funding initiatives may also be in place to support the affordability and widespread availability of these testing solutions. Overall, government policies aim to facilitate the integration of infectious disease point-of-care testing into healthcare systems to enhance public health outcomes.
The Global Infectious Disease Point-of-care Testing Market is expected to witness significant growth in the coming years due to the increasing prevalence of infectious diseases worldwide, coupled with the rising demand for rapid and accurate diagnostic solutions. Technological advancements in point-of-care testing devices, such as the development of portable and easy-to-use testing kits, are driving market expansion. Additionally, the ongoing COVID-19 pandemic has underscored the importance of point-of-care testing in containing infectious diseases and managing public health crises. As healthcare systems strive to improve patient outcomes and reduce the burden on traditional laboratory testing facilities, the adoption of point-of-care testing is likely to continue to rise, leading to a promising outlook for the Global Infectious Disease Point-of-care Testing Market.
In the Global Infectious Disease Point-of-care Testing Market, Asia Pacific is anticipated to witness significant growth due to the increasing prevalence of infectious diseases and the growing adoption of POCT technologies in countries like China and India. North America is expected to dominate the market owing to the presence of key market players, advanced healthcare infrastructure, and high healthcare expenditure. In Europe, the market is driven by the rising incidence of infectious diseases and the focus on early disease diagnosis. The Middle East and Africa region is projected to experience steady growth due to improving healthcare infrastructure and government initiatives to control infectious diseases. Latin America is also expected to show growth potential, supported by increasing awareness about POCT benefits and rising investments in healthcare infrastructure.
Global Infectious Disease Point-of-care Testing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Infectious Disease Point-of-care Testing Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Infectious Disease Point-of-care Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Global Infectious Disease Point-of-care Testing Market - Industry Life Cycle |
3.4 Global Infectious Disease Point-of-care Testing Market - Porter's Five Forces |
3.5 Global Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.7 Global Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2021 & 2031F |
3.8 Global Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Global Infectious Disease Point-of-care Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Infectious Disease Point-of-care Testing Market Trends |
6 Global Infectious Disease Point-of-care Testing Market, 2021 - 2031 |
6.1 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Applications, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Tropical Disease, 2021 - 2031 |
6.1.3 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Liver Disease, 2021 - 2031 |
6.1.4 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Respiratory Disease, 2021 - 2031 |
6.1.5 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Sexual Disorders, 2021 - 2031 |
6.1.6 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Technologies, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Lateral Flow, 2021 - 2031 |
6.2.3 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Flow-through, 2021 - 2031 |
6.2.4 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Agglutination Assays, 2021 - 2031 |
6.2.5 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Solid Phase, 2021 - 2031 |
6.3 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By End-users, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Diagnostic Laboratories, 2021 - 2031 |
6.3.3 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.4 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Home-care Settings, 2021 - 2031 |
6.3.5 Global Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Infectious Disease Point-of-care Testing Market, Overview & Analysis |
7.1 North America Infectious Disease Point-of-care Testing Market Revenues & Volume, 2021 - 2031 |
7.2 North America Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Applications, 2021 - 2031 |
7.4 North America Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Technologies, 2021 - 2031 |
7.5 North America Infectious Disease Point-of-care Testing Market, Revenues & Volume, By End-users, 2021 - 2031 |
8 Latin America (LATAM) Infectious Disease Point-of-care Testing Market, Overview & Analysis |
8.1 Latin America (LATAM) Infectious Disease Point-of-care Testing Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Applications, 2021 - 2031 |
8.4 Latin America (LATAM) Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Technologies, 2021 - 2031 |
8.5 Latin America (LATAM) Infectious Disease Point-of-care Testing Market, Revenues & Volume, By End-users, 2021 - 2031 |
9 Asia Infectious Disease Point-of-care Testing Market, Overview & Analysis |
9.1 Asia Infectious Disease Point-of-care Testing Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Applications, 2021 - 2031 |
9.4 Asia Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Technologies, 2021 - 2031 |
9.5 Asia Infectious Disease Point-of-care Testing Market, Revenues & Volume, By End-users, 2021 - 2031 |
10 Africa Infectious Disease Point-of-care Testing Market, Overview & Analysis |
10.1 Africa Infectious Disease Point-of-care Testing Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Applications, 2021 - 2031 |
10.4 Africa Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Technologies, 2021 - 2031 |
10.5 Africa Infectious Disease Point-of-care Testing Market, Revenues & Volume, By End-users, 2021 - 2031 |
11 Europe Infectious Disease Point-of-care Testing Market, Overview & Analysis |
11.1 Europe Infectious Disease Point-of-care Testing Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Applications, 2021 - 2031 |
11.4 Europe Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Technologies, 2021 - 2031 |
11.5 Europe Infectious Disease Point-of-care Testing Market, Revenues & Volume, By End-users, 2021 - 2031 |
12 Middle East Infectious Disease Point-of-care Testing Market, Overview & Analysis |
12.1 Middle East Infectious Disease Point-of-care Testing Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Infectious Disease Point-of-care Testing Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Applications, 2021 - 2031 |
12.4 Middle East Infectious Disease Point-of-care Testing Market, Revenues & Volume, By Technologies, 2021 - 2031 |
12.5 Middle East Infectious Disease Point-of-care Testing Market, Revenues & Volume, By End-users, 2021 - 2031 |
13 Global Infectious Disease Point-of-care Testing Market Key Performance Indicators |
14 Global Infectious Disease Point-of-care Testing Market - Export/Import By Countries Assessment |
15 Global Infectious Disease Point-of-care Testing Market - Opportunity Assessment |
15.1 Global Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2021 & 2031F |
15.3 Global Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2021 & 2031F |
15.4 Global Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2021 & 2031F |
16 Global Infectious Disease Point-of-care Testing Market - Competitive Landscape |
16.1 Global Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2024 |
16.2 Global Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |